Cat allergy vaccine update: Circassia Achieves Successful Phase II Clinical Results With ToleroMune® Anti-Allergy Technology

According to Circassia, Ltd., which is in the process of human clinical trials of their upcoming cat allergy vaccine, ToleroMune®, they have achieved promising results from their phase II clinical study. As their recent media release states: Circassia Ltd, a specialty biopharmaceutical company focused on controlling immune system responses, today announced positive results from a phase…

Meat allergy caused by tick bite — 1500 known U.S cases

A novel cause of anaphylaxis is being caused by a tick bite leading to sensitization to the Galactose-alpha-1,3-galactose carbohydrate. In turn, this causes delayed but often severe allergic reactions to mammalian meats, including beef and other red meats. This allergy is in the news again, and a task-force on this emerging health challenge convened in Arkansas, one…

Article in Allergic Living: Surveys Show Low Level of Allergy Awareness

In this recent article in Allergic Living Magazine, we read about two surveys that reveal just how unprepared members of the general public are to respond to allergic reactions. Given the increasing prevalence of allergies in the population, with up to 15 million Americans and between 2 and 3 million Canadians suffering from food allergies…